+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use and risk of prostate cancer in a population of men who underwent biopsy



Statin use and risk of prostate cancer in a population of men who underwent biopsy



Journal of Urology 186(1): 86-90



We determined the association between statin use and prostate cancer in men who underwent prostate biopsy. We performed a retrospective cohort study of men who underwent prostate biopsy from 2000 to 2007 at Cleveland Clinic. Statin use was determined using outpatient pharmacy records, and clinical and pathological outcomes were obtained. Multivariate logistic regression analysis to determine the effects of statins (and duration of use) was performed after adjusting for age, body mass index, African-American race, number of cores taken and prostate volume. We analyzed data from 4,204 patients, and we identified 3,182 (75.7%) not on statins and 1,022 on statins. Men diagnosed with prostate cancer on statins compared to those not taking statins were less likely to have digital rectal examination positivity (5.3% vs 8.9%, OR 0.7, p <0.01), Gleason score 7 or greater prostate cancer (61.4% vs 72.4%, OR 0.78, p = 0.02) and high volume prostate cancer (27.2 vs 31.4, p <0.01). Moreover statin users had lower prostate specific antigen compared to nonstatin users (5.13 vs 5.98, p = 0.03). Multivariate analysis adjusted risk ratios for prostate cancer diagnosis, high grade prostate cancer (Gleason score 7 or greater) and 3 or more cores positive in statin users were 0.92 (95% CI 0.85-0.98), 0.76 (95% CI 0.67-0.85) and 0.86 (95% CI 0.75-0.97) and only high grade prostate cancer persisted with length of use. Statin use was associated with a decreased risk of prostate cancer, less frequent high grade prostate cancer and lower volume of prostate cancer, suggesting that statin use has a protective effect against prostate cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911436

Download citation: RISBibTeXText

PMID: 21571344

DOI: 10.1016/j.juro.2011.03.004


Related references

Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study. Cancer Management and Research 11: 1189-1197, 2019

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score. Biomed Research International 2015: 596797, 2016

Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy. Bmc Urology 17(1): 47, 2018

Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Aging Male 20(2): 125-133, 2017

Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?. Yonsei Medical Journal 54(3): 665-671, 2014

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy. European Urology Oncology 1(2): 109-117, 2019

Statin use and prostate cancer risk in a large population-based setting. Cancer Causes and Control 19(7): 767-774, 2008

Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 1 international biopsy cohorts results from the prostate biopsy collaborative group. 2014

Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World Journal of Urology 32(1): 185-191, 2014

Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy. European Urology 53(3): 540-544, 2007

Statin use and risk of prostate cancer: results from a population-based epidemiologic study. American Journal of Epidemiology 168(3): 250-260, 2008

PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy. Technology in Cancer Research and Treatment 16(6): 1168-1172, 2018

The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique. International Urology and Nephrology 39(1): 189-195, 2006

Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of prostate cancer among men who underwent template-guided prostate biopsy: A STROBE-compliant study. Medicine 95(44): E5307, 2017

The effect of short-term dutasteride intake in early-stage prostate cancer: analysis of 148 patients who underwent three-dimensional prostate mapping biopsy. Urology 76(5): 1067-1071, 2010